Antiviral Drugs Market Professional Survey Report by 2035

コメント · 24 ビュー

Over the years, there has been a growing focus on the development of safe and effective novel antiviral therapeutics owing to the rising cases of life-threatening viral diseases

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antiviral Drugs Market, 2022 – 2035”


To get a sample copy of the latest market report, visit


The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:

  • A detailed assessment of the current market landscape of commercially available antiviral drugs. 
  • A detailed assessment of the current market landscape of clinical-stage antiviral drugs.
  • An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May).
  • A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May).
  • A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.
  • Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
    • Mechanism of Action
  • Fusion Inhibitors
  • DNA Polymerases
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Other Mechanisms


  • Target Indication
  • Human Immunodeficiency Virus Infection
  • Hepatitis
  • Herpes Simplex Virus Infection
  • Cytomegalovirus Infection\
  • Influenza
  • Coronavirus Infection
  • Other Target Indications


  • Type of Drug Target
  • Virus Targets
  • Host Targets


  • Type of Therapy
  • Monotherapy
  • Combination Therapy


  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MENA
  • Rest of the World 


Key companies covered in the report

  • AbbVie
  • AstraZeneca
  • Bristol-Myers Squibb
  • Genentech
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Johnson Johnson
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • ViiV Healthcare


For additional details, please visit


You may also be interested in the following titles:

DNA Encoded Libraries

Quantum Computing in Drug Discovery Services Market


You may also like to learn what our experts are sharing in Roots educational series:

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Novel Cell Cytometers: Need of the Hour



About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


Ben Johnson

+1 (415) 800 3415